Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women With Clinical T1-2 N0 Breast Cancer
Status: Enrolling
Updated:  7/12/2016
Froedtert Memorial Lutheran Hospital
mi
from
Milwaukee, WI
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women With Clinical T1-2 N0 Breast Cancer
Status: Enrolling
Updated: 7/12/2016
Froedtert Memorial Lutheran Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women With Clinical T1-2 N0 Breast Cancer
Status: Enrolling
Updated:  7/12/2016
Peter MacCallum Cancer Institute
mi
from
East Melbourne,
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women With Clinical T1-2 N0 Breast Cancer
Status: Enrolling
Updated: 7/12/2016
Peter MacCallum Cancer Institute
mi
from
East Melbourne,
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic
mi
from
Jacksonville, FL
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CentraCare Health Plaza
mi
from
Saint Cloud, MN
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CentraCare Health Plaza
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
Medcenter One Health System
mi
from
Bismarck, ND
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic
mi
from
Jacksonville, FL
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
Medcenter One Health System
mi
from
Bismarck, ND
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated:  7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
A Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial Of Black Cohosh In The Management Of Hot Flashes
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Joseph Medical Center
mi
from
Bloomington, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Graham Hospital
mi
from
Canton, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Graham Hospital
mi
from
Canton, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Memorial Hospital
mi
from
Carthage, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Memorial Hospital
mi
from
Carthage, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Anthony's Memorial Hospital
mi
from
Effingham, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Anthony's Memorial Hospital
mi
from
Effingham, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Eureka Community Hospital
mi
from
Eureka, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Eureka Community Hospital
mi
from
Eureka, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Galesburg Clinic, PC
mi
from
Galesburg, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Galesburg Clinic, PC
mi
from
Galesburg, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Galesburg Cottage Hospital
mi
from
Galesburg, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Mason District Hospital
mi
from
Havana, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Mason District Hospital
mi
from
Havana, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Hopedale Medical Complex
mi
from
Hopedale, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Hopedale Medical Complex
mi
from
Hopedale, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
McDonough District Hospital
mi
from
Macomb, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
McDonough District Hospital
mi
from
Macomb, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
mi
from
Moline, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
mi
from
Moline, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Moline, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Moline, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
BroMenn Regional Medical Center
mi
from
Normal, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
BroMenn Regional Medical Center
mi
from
Normal, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Community Cancer Center
mi
from
Normal, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Community Cancer Center
mi
from
Normal, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Oncology Hematology Associates of Central Illinois, PC - Ottawa
mi
from
Ottawa, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Oncology Hematology Associates of Central Illinois, PC - Ottawa
mi
from
Ottawa, IL
Click here to add this to my saved trials